Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count

Jaap Jan J Smit1, Jan Paul Ottervanger, Robbert J Slingerland

  • 1Department of Cardiology, Isala Klinieken, Zwolle, the Netherlands.

Insights

Successful reperfusion therapy for ST-segment elevation myocardial infarction (STEMI) significantly decreases white blood cell (WBC) count. Impaired myocardial reperfusion after primary percutaneous coronary intervention (PCI) is linked to persistently elevated WBC counts.

Area of Science:

  • Cardiology
  • Hematology
  • Interventional Cardiology

Background:

  • Elevated white blood cell (WBC) count in ST-segment elevation myocardial infarction (STEMI) patients predicts adverse outcomes.
  • The impact of successful reperfusion via primary percutaneous coronary intervention (PCI) on WBC count remains unclear.

Purpose of the Study:

  • To investigate the association between successful reperfusion after primary PCI in STEMI patients and changes in WBC count.
  • To determine if myocardial perfusion metrics correlate with WBC count reduction post-PCI.

Main Methods:

  • Subanalysis of the On-TIME trial involving 364 STEMI patients undergoing primary PCI.
  • WBC count measured at baseline, 6 hours, and 24 hours post-PCI.
  • Angiographic assessment of reperfusion using TIMI flow and myocardial blush grade.

Main Results:

  • Successful reperfusion (TIMI 3 flow) was associated with a significant decrease in WBC count.
  • Unsuccessful PCI (TIMI < 3 flow) resulted in persistently elevated WBC counts.
  • Improved myocardial blush and successful reperfusion independently predicted WBC count reduction.

Conclusions:

  • Impaired myocardial reperfusion following primary PCI for STEMI is associated with sustained elevation of WBC count.
  • Successful reperfusion therapy is crucial for mitigating the inflammatory response indicated by WBC levels in STEMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...